MBNL-dependent impaired development within the neuromuscular system in myotonic dystrophy type 1.
Julie Tahraoui-BoriesAntoine MérienAnchel González-BarrigaJeanne LainéCéline LeteurHélène PolvècheAlexandre CarteronJuliette Duchesne De LamotteCamille NicoleauJérome PolentesMargot JarrigeMário Gomes-PereiraErwann VentrePauline PoydenotDenis FurlingLaurent SchaefferClaire LegayCécile MartinatPublished in: Neuropathology and applied neurobiology (2023)
Beyond the application to DM1, our approach to generating a robust and reliable human neuromuscular system should facilitate disease modelling studies and drug screening assays.